270 related articles for article (PubMed ID: 18549341)
1. Clinical investigations of Toll-like receptor agonists.
Meyer T; Stockfleth E
Expert Opin Investig Drugs; 2008 Jul; 17(7):1051-65. PubMed ID: 18549341
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor agonists: a patent review (2011 - 2013).
Hussein WM; Liu TY; Skwarczynski M; Toth I
Expert Opin Ther Pat; 2014 Apr; 24(4):453-70. PubMed ID: 24456079
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of Toll-like receptor agonists and the impact on the immune system.
Engel AL; Holt GE; Lu H
Expert Rev Clin Pharmacol; 2011 Mar; 4(2):275-89. PubMed ID: 21643519
[TBL] [Abstract][Full Text] [Related]
4. The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies.
Martinsen JT; Gunst JD; Højen JF; Tolstrup M; Søgaard OS
Front Immunol; 2020; 11():1112. PubMed ID: 32595636
[TBL] [Abstract][Full Text] [Related]
5. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
6. Toll-like Receptor Agonist Conjugation: A Chemical Perspective.
Ignacio BJ; Albin TJ; Esser-Kahn AP; Verdoes M
Bioconjug Chem; 2018 Mar; 29(3):587-603. PubMed ID: 29378134
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor agonists as cancer vaccine adjuvants.
Jeon D; Hill E; McNeel DG
Hum Vaccin Immunother; 2024 Dec; 20(1):2297453. PubMed ID: 38155525
[TBL] [Abstract][Full Text] [Related]
8. TLR Agonists as Adjuvants for Cancer Vaccines.
Li JK; Balic JJ; Yu L; Jenkins B
Adv Exp Med Biol; 2017; 1024():195-212. PubMed ID: 28921471
[TBL] [Abstract][Full Text] [Related]
9. TLR based therapeutics.
Dunne A; Marshall NA; Mills KH
Curr Opin Pharmacol; 2011 Aug; 11(4):404-11. PubMed ID: 21501972
[TBL] [Abstract][Full Text] [Related]
10. Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR Agonists.
Honegr J; Soukup O; Doležal R; Malinak D; Penhaker M; Prymula R; Kuca K
Curr Med Chem; 2015; 22(29):3306-25. PubMed ID: 26295466
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor agonists in cancer therapy.
Adams S
Immunotherapy; 2009 Nov; 1(6):949-64. PubMed ID: 20563267
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of toll-like receptors in treatment of gynecological cancers.
Moradi-Marjaneh R; Hassanian SM; Hasanzadeh M; Rezayi M; Maftouh M; Mehramiz M; Ferns GA; Khazaei M; Avan A
IUBMB Life; 2019 May; 71(5):549-564. PubMed ID: 30729633
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
Li TT; Ogino S; Qian ZR
World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic and therapeutic implications of toll-like receptor ligands.
Hedayat M; Takeda K; Rezaei N
Med Res Rev; 2012 Mar; 32(2):294-325. PubMed ID: 22383179
[TBL] [Abstract][Full Text] [Related]
15. The use of Toll-like receptor 7/8 agonists as vaccine adjuvants.
Vasilakos JP; Tomai MA
Expert Rev Vaccines; 2013 Jul; 12(7):809-19. PubMed ID: 23885825
[TBL] [Abstract][Full Text] [Related]
16. An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants.
Kayesh MEH; Kohara M; Tsukiyama-Kohara K
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835108
[TBL] [Abstract][Full Text] [Related]
17. Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer Therapeutics.
Wang J; Zhang J; Wang J; Hu X; Ouyang L; Wang Y
J Med Chem; 2023 May; 66(10):6437-6462. PubMed ID: 37163340
[TBL] [Abstract][Full Text] [Related]
18. Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy.
Chakraborty S; Ye J; Wang H; Sun M; Zhang Y; Sang X; Zhuang Z
Front Immunol; 2023; 14():1227833. PubMed ID: 37936697
[TBL] [Abstract][Full Text] [Related]
19. Toll like receptor - potential drug targets in infectious disease.
Erard F; Ryffel B
Infect Disord Drug Targets; 2008 Dec; 8(4):221-31. PubMed ID: 19075797
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptors and their role in hematologic malignancies.
Wolska A; Lech-Maranda E; Robak T
Curr Mol Med; 2009 Apr; 9(3):324-35. PubMed ID: 19355914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
